These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6156212)

  • 1. Modulation of immunoregulatory responses directed toward various tumor antigens within hosts possessing distinct immunologic potentials.
    Roberts LK; Spellman CW; Daynes RA
    J Immunol; 1980 Aug; 125(2):663-72. PubMed ID: 6156212
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for two functionally distinct cross-reactive tumor antigens associated with ultraviolet light and chemically induced tumors.
    Roberts LK; Lynch DH; Daynes RA
    Transplantation; 1982 Apr; 33(4):352-60. PubMed ID: 6176053
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of the immunogenic properties of chemically induced tumors arising in hosts treated concomitantly with ultraviolet light.
    Roberts LK; Daynes RA
    J Immunol; 1980 Jul; 125(1):438-47. PubMed ID: 6966661
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific transplantation antigens of chemically induced tumors.
    Lennox ES; Sikora K
    Adv Pathobiol; 1977; (6):68-78. PubMed ID: 70987
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas.
    Parmiani G
    Transplant Proc; 1980 Mar; 12(1):50-2. PubMed ID: 7368293
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic characterization of tumor-associated transplantation antigens on MM102 mammary tumor eliciting preferentially helper T cell activity.
    Fujiwara H; Aoki H; Tsuchida T; Hamaoka T
    J Immunol; 1978 Oct; 121(4):1591-5. PubMed ID: 308971
    [No Abstract]   [Full Text] [Related]  

  • 9. T cells must recognize tumor antigen in association with self-MHC antigen.
    Lannin DR; Yu S; McKhann CF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):739-41. PubMed ID: 6168072
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapeutic effects of partially purified tumor-specific transplantation antigens on pulmonary metastases of a 3-methylcholanthrene-induced sarcoma in mice: a preliminary report.
    Tanaka T; Pellis NR; Kahan BD
    J Natl Cancer Inst; 1982 Nov; 69(5):1121-6. PubMed ID: 6957656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
    J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
    [No Abstract]   [Full Text] [Related]  

  • 12. [The H-2 complex, tumor antigens and/or virus-induced antigens].
    Levy JP
    Ann Immunol (Paris); 1977; 128(1-2):493-505. PubMed ID: 66905
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunology of tumors].
    Clerici E
    Minerva Nefrol; 1983; 30(2 Suppl):13-8. PubMed ID: 6866320
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet light induces tumors with both unique and host-associated antigenic specificities.
    DeWitt CW
    J Immunol; 1981 Jul; 127(1):329-34. PubMed ID: 6165770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The "immunologic portrait" and tumorigenicity of neoplastic cells induced in mice by 3-methylcholanthrene].
    Iaroslavtseva OA; Viksler VKh; Lavrovskiĭ VA
    Eksp Onkol; 1988; 10(6):26-9. PubMed ID: 3243190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destruction of tumor as an "innocent bystander" in an immune response specifically directed against nontumor antigens.
    Prehn RT
    Isr J Med Sci; 1973 Mar; 9(3):375-9. PubMed ID: 4145462
    [No Abstract]   [Full Text] [Related]  

  • 19. [Host's immune responses against tumor].
    Fujiwara H
    Rinsho Byori; 1989 Jul; (Spec No 82):35-41. PubMed ID: 2614962
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.